The National Bleeding Disorders Foundation (NBDF) will be leading efforts this March — during Bleeding Disorders Awareness Month, simply called BDAM — to provide…
Thrombotic thrombocytopenic purpura
Researchers are developing a potential treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) that promotes immune tolerance rather than immunosuppression, according to a study. The…
Timely diagnosis of thrombotic thrombocytopenic purpura (TTP) and access to newer treatments could improve survival and reduce complications for people in Brazil with the…
A recent report describes the case of a woman with acquired thrombotic thrombocytopenic purpura (TTP) who was later found to have an undetected human…
Following rituximab treatment, people of African ancestry with immune thrombotic thrombocytopenic purpura (iTTP) experience a relapse significantly sooner than individuals with European ancestry, a…
Treatment with Cablivi (caplacizumab-yhdp) as an add-on to standard therapy significantly reduced the number of daily plasma exchange (PEX) treatments among people with immune-mediated…
Adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP) who are in remission experience worse health-related quality of life (HRQoL), anxiety, and depression than the general…
The shape of the ADAMTS13 enzyme during remission (a period when symptoms ease or disappear) may help predict which people with immune-mediated thrombotic thrombocytopenic…
More than half of individuals who recover from an acute episode of immune-mediated thrombotic thrombocytopenic purpura (iTTP) may have silent brain damage — where…
Recognizing thrombotic thrombocytopenic purpura (TTP) in a woman with lupus and starting combined treatment — Cablivi (caplacizumab) on top of plasma exchange, corticosteroids,…
